1. ホーム
  2. 一覧
論文 特許

論文 - 一覧

  • 45 Hits
  • 検索条件 : 絞込み (MeSH = Ovarian Neoplasms / metabolism)
生物種 リソース名 タイトル
ヒト・動物細胞 A549 A stearate-rich diet and oleate restriction directly inhibit tumor growth via the unfolded protein response.
ヒト・動物細胞 KGN(RCB1154) Myo-Inositol and D-Chiro-Inositol Reduce DHT-Stimulated Changes in the Steroidogenic Activity of Adult Granulosa Cell Tumors.
ヒト・動物細胞 JHOS-4(RCB1678) LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake.
ヒト・動物細胞 BALL-1(RCB0256) PD-1+ Tim3+ tumor-infiltrating CD8 T cells sustain the potential for IFN-γ production, but lose cytotoxic activity in ovarian cancer.
ヒト・動物細胞 JHOC-5(RCB1520) Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers.
ヒト・動物細胞 JHOC-5(RCB1520) , JHOC-7(RCB1688) , JHOC-9(RCB2226) , JHOM-1(RCB1676) , JHOS-3(RCB1546) Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition.
ヒト・動物細胞 HHUA(RCB0658) Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells.
ヒト・動物細胞 NIH:OVCAR-3(RCB2135) Sulfated glycosaminoglycans mediate prion-like behavior of p53 aggregates.
ヒト・動物細胞 293T(RCB2202) Species-Dependent Enhancement of Ovarian Cancer G Protein-Coupled Receptor 1 Activation by Ogerin.
ヒト・動物細胞 JHOC-7(RCB1688) , JHOC-9(RCB2226) MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53.
ヒト・動物細胞 JHOC-7(RCB1688) Anti-tumor activity of dual inhibition of phosphatidylinositol 3-kinase and MDM2 against clear cell ovarian carcinoma.
ヒト・動物細胞 OVK18(RCB1903) Upregulation of cyclase-associated actin cytoskeleton regulatory protein 2 in epithelial ovarian cancer correlates with aggressive histologic types and worse outcomes.
ヒト・動物細胞 KGN(RCB1154) Disruption of 17β-estradiol secretion by persistent organic pollutants present in human follicular fluid is dependent on the potential of ovarian granulosa tumor cell lines to metabolize estrogen.
ヒト・動物細胞 JHOC-9(RCB2226) Therapeutic preferability of gemcitabine for ARID1A-deficient ovarian clear cell carcinoma.
ヒト・動物細胞 JHOC-5(RCB1520) Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma.
ヒト・動物細胞 HHUA(RCB0658) Erucylphosphocholine shows a strong anti-growth activity in human endometrial and ovarian cancer cells.
ヒト・動物細胞 KGN(RCB1154) The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription.
ヒト・動物細胞 JHUEM-2(RCB1551) Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers.
ヒト・動物細胞 JHOC-5(RCB1520) PIK3CA hotspot mutations and cyclooxygenase-2 expression in ovarian clear cell carcinomas: a close association with stromal features.
ヒト・動物細胞 JHOC-5(RCB1520) Low uptake of fluorodeoxyglucose in positron emission tomography/computed tomography in ovarian clear cell carcinoma may reflect glutaminolysis of its cancer stem cell-like properties.